IL131801D0 - Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome and gestational diabetes - Google Patents

Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome and gestational diabetes

Info

Publication number
IL131801D0
IL131801D0 IL13180198A IL13180198A IL131801D0 IL 131801 D0 IL131801 D0 IL 131801D0 IL 13180198 A IL13180198 A IL 13180198A IL 13180198 A IL13180198 A IL 13180198A IL 131801 D0 IL131801 D0 IL 131801D0
Authority
IL
Israel
Prior art keywords
treatment
use
polycystic ovary
ovary syndrome
gestational diabetes
Prior art date
Application number
IL13180198A
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US08/868,608 priority Critical patent/US6046222A/en
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Priority to PCT/US1998/010472 priority patent/WO1998055121A1/en
Publication of IL131801D0 publication Critical patent/IL131801D0/en

Links

IL13180198A 1993-09-15 1998-05-21 Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome and gestational diabetes IL131801D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US08/868,608 US6046222A (en) 1993-09-15 1997-06-04 Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome, gestational diabetes and disease states at risk for progressing to noninsulin-dependent diabetes mellitus
PCT/US1998/010472 WO1998055121A1 (en) 1997-06-04 1998-05-21 Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome and gestational diabetes

Publications (1)

Publication Number Publication Date
IL131801D0 true IL131801D0 (en) 2001-03-19

Family

ID=25352002

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13180198A IL131801D0 (en) 1993-09-15 1998-05-21 Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome and gestational diabetes

Country Status (15)

Country Link
US (3) US6046222A (en)
EP (1) EP0984780B1 (en)
JP (1) JP2002511859A (en)
KR (1) KR20010013337A (en)
AT (1) AT303147T (en)
BR (1) BR9809968A (en)
CA (1) CA2283319A1 (en)
DE (1) DE69831406D1 (en)
HU (1) HU0003876A3 (en)
IL (1) IL131801D0 (en)
IS (1) IS5194A (en)
NO (1) NO995932L (en)
PL (1) PL348773A1 (en)
WO (1) WO1998055121A1 (en)
ZA (1) ZA9804798B (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6046222A (en) * 1993-09-15 2000-04-04 Warner-Lambert Company Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome, gestational diabetes and disease states at risk for progressing to noninsulin-dependent diabetes mellitus
US20020177612A1 (en) * 1997-06-05 2002-11-28 Smithkline Beecham P.I.C. Composition comprising 5-[4-[2-(N-methyl-N-2-pyridy)amino)ethoxy]benzyl]thiazolidine-2,4-dione
US20020006939A1 (en) * 1997-10-13 2002-01-17 Smithkline Beecham P.L.C. Use of thiazolidinediones for the treatment of hyperglycaemia
US20010031776A1 (en) * 1997-10-13 2001-10-18 Smithkline Beecham P.L.C. Use of thiazolidinediones for the treatment of hyperglycaemia
US7105552B2 (en) * 1998-05-08 2006-09-12 Theracos, Inc. Heterocyclic analogs of diphenylethylene compounds
US7407978B2 (en) * 1999-04-06 2008-08-05 Theracos, Inc. Heterocyclic analogs of diphenylethylene compounds
US6605642B2 (en) 1999-04-05 2003-08-12 City Of Hope Inhibitors of formation of advanced glycation endproducts (AGES)
US7030133B2 (en) 1999-04-05 2006-04-18 City Of Hope Inhibitors of formation of advanced glycation endproducts (AGEs)
JP2002543118A (en) * 1999-04-29 2002-12-17 シティ・オブ・ホープ Pentoxifylline, pioglitazone and metformin is the inhibitor of the formation of advanced glycation end products (age)
US6468507B1 (en) * 2000-05-01 2002-10-22 Aeropharm Technology, Inc. Non-aqueous aerosol formulation comprising rosiglitazone maleate, a non-aqueous carrier, and an amino acid stabilizer
AU2002253838B2 (en) * 2000-10-30 2006-11-09 Ortho-Mcneil Pharmaceutical, Inc. Combination therapy comprising anti-diabetic and anticonvulsant agents
WO2002080935A1 (en) * 2001-04-04 2002-10-17 Ortho Mcneil Pharmaceutical, Inc. Combination therapy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators
AT423559T (en) * 2001-04-04 2009-03-15 Ortho Mcneil Janssen Pharm Combination therapy glukoseresorptionshemmer and modulators PPAR
GB0108863D0 (en) * 2001-04-10 2001-05-30 Leuven K U Res & Dev Combinational therapy
US20030220374A1 (en) * 2002-01-14 2003-11-27 Pharmacia Corporation Compositions and methods of treatment involving peroxisome proliferator-activated receptor-gamma agonists and cyclooxygenase-2 selective inhibitors
US20030212138A1 (en) * 2002-01-14 2003-11-13 Pharmacia Corporation Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor
KR100450700B1 (en) * 2002-03-22 2004-10-01 주식회사종근당 Thiazolidinedione derivatives and pharmaceutical composition comprising the same
US20030220300A1 (en) * 2002-05-14 2003-11-27 Hwang Cheng Shine Reduction of hair growth
EP1515701B1 (en) 2002-06-17 2014-09-17 Inventia Healthcare Private Limited Process for the manufacture of multilayer tablet compositions comprising thiazolidinedione and biguanide
WO2004100895A2 (en) * 2003-05-13 2004-11-25 Pharmacia Corporation Compositions of a cyclooxygenase-2 selective inhibitor and a peroxisome proliferator activated receptor agonist for the treatment of ischemic mediated central nervous system disorders
EP2269601A1 (en) 2003-10-27 2011-01-05 City of Hope LR-9, LR-74 and LR-90 for use in treating complications resulting from diabetes
US20050112075A1 (en) * 2003-11-25 2005-05-26 Hwang Cheng S. Reduction of hair growth
US20050249685A1 (en) * 2004-04-27 2005-11-10 Natalia Botchkareva Reduction of hair growth
US7833513B2 (en) 2004-12-03 2010-11-16 Rhode Island Hospital Treatment of Alzheimer's Disease
KR20070086176A (en) * 2004-12-22 2007-08-27 더 지렛트 캄파니 Reduction of hair growth
AU2005319166A1 (en) * 2005-12-21 2006-06-29 The Gillette Company Reduction of hair growth with survivin inhibitors
US7618956B2 (en) * 2005-05-31 2009-11-17 The Gillette Company Reduction of hair growth
US20070249561A1 (en) * 2006-04-25 2007-10-25 Taylor Bradley K Pharmacological method for treatment of neuropathic pain
US7973062B2 (en) * 2008-02-22 2011-07-05 The Ohio State University Research Foundation Androgen receptor-ablative agents
WO2011014649A1 (en) 2009-07-29 2011-02-03 Duke University Compositions and methods for inhibiting hair growth
JP5847085B2 (en) 2009-10-09 2016-01-20 ザ オハイオ ステート ユニバーシティー リサーチ ファウンデーション Thiazolidinedione energy restriction mimetic

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3174901A (en) * 1963-01-31 1965-03-23 Jan Marcel Didier Aron Samuel Process for the oral treatment of diabetes
JPS6242903B2 (en) * 1978-08-04 1987-09-10 Takeda Chemical Industries Ltd
FR2449446B1 (en) * 1979-02-22 1981-04-30 Somachim
JPH0257546B2 (en) * 1982-01-07 1990-12-05 Takeda Chemical Industries Ltd
JPH0231079B2 (en) * 1983-08-30 1990-07-11 Sankyo Co Chiazorijinjudotaioyobisonoseizoho
CN1003445B (en) * 1984-10-03 1989-03-01 武田药品工业株式会社 Process for the production of thiazolidiredions derivative and use
AR240698A1 (en) * 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Process for the preparation of 5-(4-(2-(5-ethyl-2-pyridil)-ethoxy)benzyl)-2,4-thiazolodinedione and their salts
HU210339B (en) * 1985-05-21 1995-03-28 Pfizer Process for preparing thiazolidinediones and their pharmaceutical compositions haring hypoglycemic effect
US4873255A (en) * 1987-02-04 1989-10-10 Sankyo Company Limited Thiazolidinone derivatives, their preparation and their use
FI91869C (en) * 1987-03-18 1994-08-25 Tanabe Seiyaku Co Process for the preparation of an antidiabetic agent for bensoksatsolijohdannaisten
EP0295828A1 (en) * 1987-06-13 1988-12-21 Beecham Group Plc Novel compounds
DE3856378T2 (en) * 1987-09-04 2000-05-11 Beecham Group Plc substituted thiazolidinedione derivatives
US5232925A (en) * 1987-09-04 1993-08-03 Beecham Group P.L.C. Compounds
US5194443A (en) * 1987-09-04 1993-03-16 Beecham Group P.L.C. Compounds
US5260445A (en) * 1987-09-04 1993-11-09 Beecham Group P.L.C. 2,4-thiazolidinediones
US5061717A (en) * 1988-03-08 1991-10-29 Pfizer Inc. Thiazolidinedione hypoglycemic agents
MX15171A (en) * 1988-03-08 1993-05-01 Pfizer Hypoglycemic thiazolidinedione derivatives
US5223522A (en) * 1988-03-08 1993-06-29 Pfizer Inc. Thiazolidinedione hypoglycemic agents
US5120754A (en) * 1988-03-08 1992-06-09 Pfizer Inc. Thiazolidinedione hypoglycemic agents
US4897405A (en) * 1989-04-21 1990-01-30 American Home Products Corporation Novel naphthalenylalkyl-3H-1,2,3,5-oxathiadiazole 2-oxides useful as antihyperglycemic agents
GB8919434D0 (en) * 1989-08-25 1989-10-11 Beecham Group Plc Novel compounds
GB8919417D0 (en) * 1989-08-25 1989-10-11 Beecham Group Plc Novel compounds
WO1991003474A1 (en) * 1989-08-29 1991-03-21 Pfizer Inc. Hypoglycemic thiazolidinedione derivatives
WO1991007107A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Oxazolidinedione hypoglycemic agents
DE3942236A1 (en) * 1989-12-21 1991-06-27 Bosch Siemens Hausgeraete The catalytic coating agents, process for its preparation and with the coating agents available cooking, baking, roasting or grilling devices or parts
EP0514452B2 (en) * 1990-02-09 2000-07-19 The Upjohn Company Use of insulin sensitizing agents to treat hypertension
US5126324A (en) * 1990-06-07 1992-06-30 Genentech, Inc. Method of enhancing growth in patients using combination therapy
GB9017218D0 (en) * 1990-08-06 1990-09-19 Beecham Group Plc Novel compounds
GB9023585D0 (en) * 1990-10-30 1990-12-12 Beecham Group Plc Novel compounds
GB9023583D0 (en) * 1990-10-30 1990-12-12 Beecham Group Plc Novel compounds
US5221685A (en) * 1991-02-01 1993-06-22 Ube Industries, Ltd. Thiazoline derivative, process for preparing the same and chemical for controlling noxious organisms containing the same
ES2092112T3 (en) * 1991-06-25 1996-11-16 Pfizer thiazolidinedione hypoglycemic agents.
EP0603419A4 (en) * 1992-07-13 1994-10-12 Japan Tobacco Inc Novel thiazolidinedione compound and use thereof.
US5221686A (en) * 1992-08-04 1993-06-22 American Home Products Corporation Spiro[1,2-benzisothiazole-3(2H),5'-oxazolidine]-2',4'-dione 1,1-dioxides as antihyperglycemic agents
AU675996B2 (en) * 1992-10-29 1997-02-27 Genentech Inc. Method for treatment or prevention of obesity
US6046222A (en) * 1993-09-15 2000-04-04 Warner-Lambert Company Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome, gestational diabetes and disease states at risk for progressing to noninsulin-dependent diabetes mellitus
US5457109A (en) * 1993-09-15 1995-10-10 Warner-Lambert Company Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus
US5874454A (en) * 1993-09-15 1999-02-23 Warner-Lambert Company Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome, gestational diabetes and disease states at risk for progressing to noninsulin-dependent diabetes mellitus
DE69435039D1 (en) * 1993-09-15 2007-12-13 Daiichi Sankyo Co Ltd Use of thiazolidinediones for preventing or delaying the onset of non-insulin dependent diabetes mellitus (NIDDM)

Also Published As

Publication number Publication date
HU0003876A3 (en) 2002-04-29
NO995932L (en) 1999-12-03
WO1998055121A1 (en) 1998-12-10
EP0984780B1 (en) 2005-08-31
KR20010013337A (en) 2001-02-26
ZA9804798B (en) 1998-12-29
US6046222A (en) 2000-04-04
AT303147T (en) 2005-09-15
BR9809968A (en) 2000-08-01
DE69831406D1 (en) 2005-10-06
IS5194A (en) 1999-09-24
EP0984780A1 (en) 2000-03-15
US6130216A (en) 2000-10-10
CA2283319A1 (en) 1998-12-10
NO995932D0 (en) 1999-12-03
HU0003876A2 (en) 2002-01-28
US5972944A (en) 1999-10-26
JP2002511859A (en) 2002-04-16
PL348773A1 (en) 2002-06-17

Similar Documents

Publication Publication Date Title
EP1189895B8 (en) Thiazole and oxazole derivatives and their pharmaceutical use
AU775063C (en) Modified exendins and exendin agonists
PT733644E (en) Insulinotropic complexes of the glucagin type compositions and methods of use
AU5372198A (en) Absorbent articles having cuffs with skin care composition disposed thereon
IL149374D0 (en) New use and novel n-azabicyclo-amide derivatives
IL111077D0 (en) Pharmacologically active pyridine derivatives and processes for the preparation thereof
AU6988394A (en) Methods and compositions for inducing sleep
PL179001B1 (en) Personal care absorbent article
SI1523982T1 (en) Plenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
AU1401595A (en) Liquid absorbent material for personal care absorbent articles and the like
AU1766497A (en) Insulin derivatives and their use
IL113844A (en) N-(alpha-ETHYLBENZYL)-3-HYDROXY-2-PHENYLQUINOLINE-4-CARBOXAMIDE AND ITS USE IN THE PREPARATION OF MEDICAMENTS
ZA9510458B (en) Absorbent composites and absorbent articles containing the same
PT946191E (en) Use of glp-1 analogues and derivatives administered underlying in the adjustment of obesity
HK1052497A1 (en) Benzamides and related
HU9904361A3 (en) Use of isobutylgaba and its derivatives for the treatment of pain
HRP980044A2 (en) Thiazole benzenesulfonamides as beta3 antagonists for the treatment of diabetes and obesity
PH31468A (en) Oxazolidinedione derivatives and their use.
ZA9400711B (en) Heterocyclic compounds and their preparation and use
NZ231552A (en) Halogenated thiazole derivatives and fungicidal compositions
PL306452A1 (en) Novel compounds and pharmaceutical agent
PT1246920E (en) Prevention of affections associated with porcine circovirus-2
PT1052254E (en) Nitrogenous heterocyclic derivatives and medicine thereof
EP1194146A4 (en) Arylthiazolidinedione and aryloxazolidinedione derivatives
NZ264119A (en) 1-benzenesulphonyl-1,3-dihydrobenzimidazol-2-one derivatives and medicaments